Syndrome | |||
VITT or VITT-like disorder | ITP | TTP | |
Thrombocytopenia |
|
|
|
Thrombosis |
|
|
|
Other clinical |
|
|
|
Other laboratory |
|
|
|
Diagnostic confirmation |
|
|
|
Management implications* |
|
|
|
aPTT: activated partial thromboplastin time; COVID-19: coronavirus disease 2019; ELISA: enzyme-linked immunosorbent assay; ITP: immune thrombocytopenia; IVIG: intravenous immune globulin; PT: prothrombin time; TPO-RA: thrombopoietin receptor agonist; TTP: thrombotic thrombocytopenia; VITT: virus-induced immune thrombotic thrombocytopenia, previously called vaccine-induced immune thrombotic thrombocytopenia; VTE: venous thromboembolism.
* This is only intended to summarize major differences in management and to emphasize the importance of making the correct diagnosis. Refer to UpToDate for detailed management discussions.
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟